139 related articles for article (PubMed ID: 6284627)
1. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
Berlan M; Carpene C; Lafontan M; Dang-Tran L
Horm Metab Res; 1982 May; 14(5):257-60. PubMed ID: 6284627
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dog fat cell adrenoceptors: variations in alpha-2 and beta adrenergic receptors distribution according to the extent of the fat deposits and the anatomical location.
Taouis M; Berlan M; Montastruc P; Lafontan M
J Pharmacol Exp Ther; 1987 Sep; 242(3):1041-9. PubMed ID: 2821223
[TBL] [Abstract][Full Text] [Related]
3. Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine.
Villeneuve A; Carpene C; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1985 May; 233(2):433-40. PubMed ID: 2987483
[TBL] [Abstract][Full Text] [Related]
4. Obesity modifies the adrenergic status of dog adipose tissue.
Taosis M; Valet P; Estan L; Lafontan M; Montastruc P; Berlan M
J Pharmacol Exp Ther; 1989 Sep; 250(3):1061-6. PubMed ID: 2550613
[TBL] [Abstract][Full Text] [Related]
5. [The role of beta and alpha adrenergic receptors in the lipolytic effect of catecholamines on dog adipocytes (author's transl)].
Berlan M; Dang Tran L
J Physiol (Paris); 1978 Dec; 74(6):601-8. PubMed ID: 218001
[TBL] [Abstract][Full Text] [Related]
6. Interplay of alpha-2 and beta adrenoceptors in the control of free fatty acid release from bone marrow adipose tissue.
Tran MA; Lac DT; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1984 Jul; 230(1):228-31. PubMed ID: 6086878
[TBL] [Abstract][Full Text] [Related]
7. Influence of androgenic status on the alpha 2/beta-adrenergic control of lipolysis in white fat cells: predominant alpha 2-antilipolytic response in testosterone-treated-castrated hamsters.
Pecquery R; Leneveu MC; Giudicelli Y
Endocrinology; 1988 Jun; 122(6):2590-6. PubMed ID: 2453344
[TBL] [Abstract][Full Text] [Related]
8. Fat cell adrenoceptors: inter- and intraspecific differences and hormone regulation.
Lafontan M; Berlan M; Carpene C
Int J Obes; 1985; 9 Suppl 1():117-27. PubMed ID: 2999011
[TBL] [Abstract][Full Text] [Related]
9. The effect of fasting on the adrenergic receptor activity of human adipocytes.
Burns TW; Boyer PA; Terry BE; Langley PE; Robison GA
J Lab Clin Med; 1979 Sep; 94(3):387-94. PubMed ID: 224120
[TBL] [Abstract][Full Text] [Related]
10. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life.
Marcus C; Karpe B; Bolme P; Sonnenfeld T; Arner P
J Clin Invest; 1987 Jun; 79(6):1812-8. PubMed ID: 3034983
[TBL] [Abstract][Full Text] [Related]
11. Catecholamine-induced lipolysis in adipose tissue of the elderly.
Lönnqvist F; Nyberg B; Wahrenberg H; Arner P
J Clin Invest; 1990 May; 85(5):1614-21. PubMed ID: 2159025
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the alpha 2/beta-adrenoceptor-coupled adenylate cyclase system and their relationship with adrenergic responsiveness in hamster fat cells from different anatomical sites.
Dieudonne MN; Pecquery R; Giudicelli Y
Eur J Biochem; 1992 Apr; 205(2):867-73. PubMed ID: 1349284
[TBL] [Abstract][Full Text] [Related]
13. [Identification of alpha-2 adrenergic receptors in rabbit adipocytes].
Nasraoui A; Rozen R; Apfelbaum M
Arch Inst Pasteur Tunis; 1988; 65(3-4):255-60. PubMed ID: 2854961
[TBL] [Abstract][Full Text] [Related]
14. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742
[TBL] [Abstract][Full Text] [Related]
15. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Langin D; Portillo M; Dauzats M; Lafontan M
Endocrinology; 1992 Jan; 130(1):307-15. PubMed ID: 1309335
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying regional differences in lipolysis in human adipose tissue.
Wahrenberg H; Lönnqvist F; Arner P
J Clin Invest; 1989 Aug; 84(2):458-67. PubMed ID: 2503539
[TBL] [Abstract][Full Text] [Related]
18. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha 2 adrenoceptor properties.
Berlan M; Lafontan M
Eur J Clin Invest; 1985 Dec; 15(6):341-8. PubMed ID: 3007159
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the alpha 2 nature of the alpha-adrenergic receptor inhibiting lipolysis in human fat cells.
Lafontan M; Berlan M
Eur J Pharmacol; 1980 Aug; 66(1):87-93. PubMed ID: 6105967
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog.
Taouis M; Berlan M; Montastruc P; Lafontan M
J Pharmacol Exp Ther; 1988 Dec; 247(3):1172-80. PubMed ID: 2905003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
